Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2111-2116

  Ono, Taeko ^a   Kanzaki, Susumu ^a   Seino, Yoshiki ^a   Baylink, David J ^b   Mohan, Subburaman ^b,c  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5;

ADOLESCENT; ARTICLE; BONE GROWTH; CHILD; CLINICAL ARTICLE; CORTICAL BONE; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME SPECIFICITY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HUMAN; MALE; OSSIFICATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ADOLESCENT; ALKALINE PHOSPHATASE; BONE AND BONES; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; ISOENZYMES; MALE; SOMATOMEDINS;

EID: 0030013093     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2111     Document Type: Article

References (40)

1. Schoenle E, Zapf J, Hauri C, Steiner T, Froesch ER. 1985 Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh). 108:167-174.
2. Schiltz PM, Ohta T, Glass D, Mohan S, Baylink DJ. 1992 Growth hormone stimulates cortical bone formation in immature hypophysectomized rats. Endoer Res. 18:19-30.
3. Kanzaki S, Hosoda K, Moriwake T, et al. 1992 Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab. 75:104-1109.
4. Daughaday WH. 1989 Growth hormone: normal synthesis, secretion, control, and mechanisms of action. In: DeGroot LJ, ed. Endocrinology. Philadelphia: Saunders; 318-329.
5. Mohan S, Jennings JC, Linkhart TA, Baylink DJ. 1988 Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta. 966:44-55.
6. Kanzaki S, Baxter RC, Knutsen R, Baylink DJ, Mohan S. 1995 Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein 3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res. 10:854-858.
7. Mohan S, Baylink DJ. 1990 Bone growth factors. Clin Orthop. 263:30-48.
8. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
9. Shaar CJ, Tinsley FC, Smith MC, Clemens JA, Neubauer BL. 1989 Recombinant DNA-derived human insulin-like growth factor II (hIGF-II) stimulates growth in hypophysectomixed rats. Endocr Res. 15:403-411.
10. van Buul-Offers SC, Reijnen-Gresnigt MG, Hoogerbrugge CM, Bloemen RJ, Kuper CF, Van den Brande JL. 1994. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect on the liver of Snell dwarf mice. Endocrinology. 135:977-985.
11. Jorgensen JOL, Blum WF, Moller N, Ranke MB, Christiansen JS. 1991 Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH deficient patients. J Clin Endocrinol Metab. 72:582-587.
12. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:470-479.
13. Zapf J, Walter H, Froesch ER. 1981 Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest. 68:1321-1330.
14. Mohan S, Strong DD, Linkhart TA, Baylink DJ. 1994 Regulation and actions of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in bone: physiological and clinical implications. In. Baxter RC, Gluckman PD, Rosenfeld RG, eds. The insulin-like growth factors. New York: Elsevier; 205-215.
15. Bagi CM, DeLeon E, Brommage R, Adams S, Rosen D, Sommer A. 1995 Systemic administration of rhIGF-1 or rhIGF-1/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats. Bone. 16:263S-269S.
16. Bautista CM, Baylink DJ, Mohan S. 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun. 176:756-763.
17. Andress DL, Birnbaum RS. 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 267:22467-22472.
18. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1298.
19. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R. 1994 Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab. 79: 1361-1366.
20. Mandel S, Moreland E, Nichols V, Hanna C, Lafranchi S. 1995 Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. J Clin Endocrinol Metab. 80:190-194.
21. Thompson JL, Butterfield GE, Marcus R, et al. 1995 The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab. 80:1845-1852.
22. Mohan S, Baylink DJ. 1995 Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab. 80: 637-647.
23. Nakao Y, Hilliker S, Baylink DJ, Mohan S. 1994 Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro. J Bone Miner Res. 9:865-872.
24. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink DJ. 1995 Development, validation and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab. 80:2638-2645.
25. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. 1977 Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 60:648-657.
26. Copeland KC, Underwood LE, van Wyk JJ. 1980 Induction of imnumoreactive somatomedin C in human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. J Clin Endocrinol Metab. 50:690-697.
27. Rosenfeld RG, Kemp SF, Hintz RL. 1981 Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab. 53:611-617.
28. Dean HJ, Kellett JG, Bala RM, et al. 1982 The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children. J Clin Endocrinol Metab. 55:1167-1173.
29. Hardouin S, Gourmelen M, Noguiez PD, et al. 1989 Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab. 69:1291-1301.
30. Marcus R, Butterfield G, Holloway L, et al. 1990 Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab. 70:519-527.
31. Crofton PM, Stirling HF, Christopher CJH. 1995 Bone alkaline phosphatase and height velocity in short normal children undergoing growth-promoting treatments: Longitudinal study. Clin Chem. 41:672-678.
32. Garnero P, Delmas PD. 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 77:1046-1053.
33. Slootweg MC, Ohlsson C, van Elk EJ, Netenlenbos JC, Andress DL. Insulin like growth factor binding protein-5 stimula tes growth hormone (GH) receptor binding and potentiates GH-stimulatecl mitogenesis in rat osteosarcoma cells [Abstract]. Proc of the 77th Annual Meet of The Endocrine Soc. 1945.
34. Mohan S, Nakao Y, Honda Y, et al. 1495 Studies on the mechanisms by which IGFBP-4 and IGFBP-S modulate IGF actions in bone cells. J Biol Chem. 270: 20424-20431.
35. Camacho-Hubner C, Busby Jr WH, McCusker RH, Wright G, Clemmons DR. 1942 Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem. 267:11949-11956.
36. Conover CA, Kiefer MC. 1993 Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab. 76:1153-1159.
37. Kanzaki S, Hilliker S, Baylink DJ, Mohan S. 1994 Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology. 134:383-392.
38. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ. 1992 Studies on regulation of insulin-like growth factor binding protein (IGFBP-3 and IGFBP-4 production in human bone cells. Acta Endocrinol (Copenh). 127:555-564.
39. Hassager C, Fitzpatrick LA, Spencer EM, Riggs BL, Conover CA. 1992 Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. J Clin Endocrinol Metab. 75:228-233.
40. McCarthy TL, Casinghino S, Centrella M, Canalis E. 1994 Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone and the insulin-like growth factors. J Cell Physiol. 160:163-175.